STAG2 as a biomarker for prediction of recurrence in papillary non-muscle invasive bladder cancer

被引：0
|
作者：
Lelo, Alana [1 ]
Harris, Brent T. [1 ]
Berry, Deborah L. [1 ]
Chaldekas, Krysta [1 ]
Kumar, Anagha [2 ]
Solomon, David [3 ]
Simko, Jeffry [3 ]
Bhattacharyya, Pritish [4 ]
Mannion, Ciaran [4 ]
Kim, Jung-Sik [1 ]
Philips, George [5 ]
Waldman, Todd [1 ]
机构：
[1] Georgetown Univ, Washington, DC USA
[2] Medstar Hlth Res Inst, Washington, DC USA
[3] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[4] Hackensack Univ Med Ctr, Hackensack, NJ USA
[5] Medstar Washington Hosp Ctr, Washington, DC USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1558
引用
收藏
页数：2
相关论文
共 50 条
  • [21] STAG2 acts as a transcriptional repressor and promotes invasion of muscle invasive bladder cancer cells
    Athans, Sarah R.
    Krishnan, Nithya
    Ramakrishnan, Swathi
    Gomez, Eduardo Cortes
    Lage-Vickers, Sofia
    Rak, Monika
    Kazmierczak, Zara
    Stablewski, Aimee
    Attwood, Kristopher
    Wang, Jianmin
    Woloszynska, Anna
    CANCER RESEARCH, 2022, 82 (12)
  • [22] TROP2 is associated with the recurrence of patients with non-muscle invasive bladder cancer
    Zhang, Lianhua
    Yang, Guoliang
    Jiang, Haifeng
    Liu, Mengyao
    Chen, Haige
    Huang, Yiran
    Wang, Zhiwei
    Bo, Juanjie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1643 - 1650
  • [23] PREDICTION OF RECURRENCE AND PROGRESSION IN THE CONTEXT OF THE CHARLSON COMORBIDITY INDEX IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
    Yang, Serena
    Chen, Guoqing
    Godoy, Guilherme
    Lerner, Seth
    JOURNAL OF UROLOGY, 2013, 189 (04): : E729 - E729
  • [24] Prediction of recurrence of non-muscle invasive bladder cancer: The role of androgen receptor and miRNA-2909
    Muzaail, Hazim Hadi
    El-Assmy, Ahmed
    Harraz, Ahmed M.
    Awadalla, Amira
    Shokeir, Ahmed A.
    Abdel-Aziz, A. F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 197.e25 - 197.e35
  • [25] Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?
    Ucpinar, Burak
    Erbin, Akif
    Ayranci, Ali
    Caglar, Ufuk
    Alis, Deniz
    Basal, Seref
    Sarilar, Omer
    Akbulut, Mehmet Fatih
    JOURNAL OF BUON, 2019, 24 (04): : 1659 - 1665
  • [26] Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features
    Tokuyama, Naoto
    Saito, Akira
    Muraoka, Ryu
    Matsubara, Shuya
    Hashimoto, Takeshi
    Satake, Naoya
    Matsubayashi, Jun
    Nagao, Toshitaka
    Mirza, Aashiq H.
    Graf, Hans-Peter
    Cosatto, Eric
    Wu, Chin-Lee
    Kuroda, Masahiko
    Ohno, Yoshio
    MODERN PATHOLOGY, 2022, 35 (04) : 533 - 538
  • [27] STAG2 expression imparts distinct therapeutic vulnerabilities in muscle-invasive bladder cancer cells
    Athans, Sarah R.
    Withers, Henry
    Stablewski, Aimee
    Gurova, Katerina
    Ohm, Joyce
    Woloszynska, Anna
    ONCOGENESIS, 2025, 14 (01):
  • [28] Urinary pH and the risk of recurrence in patients with non-muscle invasive bladder cancer
    Stone, Benjamin V.
    Ayangbesan, Abimbola
    Taylor, Benjamin L.
    Golombos, David M.
    Lewicki, Patrick
    Al Awamlh, Bashir Al Hussein
    O'Malley, Padraic
    Kaplan, Steven A.
    Scherr, Douglas S.
    Chughtai, Bilal
    CANADIAN JOURNAL OF UROLOGY, 2018, 25 (04) : 9407 - 9412
  • [29] The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer
    Ho, Patrick
    Moran, George W.
    Wang, Vinson
    Li, Gen
    Virk, Renu K.
    McKiernan, James M.
    Anderson, Christopher B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 60.e11 - 60.e16
  • [30] Role of urinary cotinine level in the recurrence of non-muscle invasive bladder cancer
    Abdessater, M.
    Kanbar, A.
    El Khoury, J.
    Akl, H.
    Halabi, R.
    Assaf, S.
    Hanna, E.
    Boustany, J.
    El Khoury, R.
    EUROPEAN UROLOGY, 2021, 79 : S1000 - S1000
12345